IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort studyJung-Ta Kao, Yi‐Ying Wu|BMC Gastroenterology|2015Cited by 65
Evaluation of dose-efficacy of sorafenib and effect of transarterial chemoembolization in hepatocellular carcinoma patients: a retrospective studyWang-De Hsiao, Jung-Ta Kao, Po‐Heng Chuang et al.|BMC Gastroenterology|2016Cited by 14